Director Finance, Global OE and Customers. Product & Technology at Clairo

Milwaukee, Wisconsin, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Automotive, Manufacturing, TechnologyIndustries

Requirements

Bachelor’s degree in Finance, Accounting, or related field; MBA or CPA preferred
12+ years of progressive finance experience in a multinational, matrixed organization, ideally with exposure to manufacturing, product development, or engineering environments
Proven track record of strategic business partnership and financial leadership in complex, global settings
Strong analytical and problem-solving skills with the ability to translate data into actionable insights
Experience with capital planning, product costing, and investment analysis

Responsibilities

Serve as a trusted advisor to the VP/GM and leadership team of Global OE Customer & Technology group, driving alignment between financial strategy and business objectives
Lead financial planning and analysis for the Global OE and Customer & Technology organization, including long-range planning, annual budgeting, and monthly outlooking
Support strategic initiatives such as product and business innovation, cost transformation, and customer growth through robust financial modeling and scenario analysis
Lead monthly program reviews with financial insights across capital, tooling, engineering spend, labor, and material costs to ensure business case commitments are met
Partner with Product Technology Managers to establish product cost targets, profitability metrics, and long-range product financial plans
Track and report product cost savings initiatives and support pricing analysis for new and existing products
Drive monthly operating reviews and executive-level presentations on business group strategy, performance, and financial outlook
Ensure timely and accurate completion of monthly close activities related to Customer & Technology, adhering to corporate accounting policies, SOX compliance, and internal controls
Lead financial analysis for capital investment business cases, ensuring alignment with strategic priorities and return expectations

Skills

Financial Planning

Financial Analysis

Financial Modeling

Scenario Analysis

Budgeting

Long-range Planning

Product Costing

Profitability Analysis

Capital Management

Tooling Finance

Engineering Spend

Monthly Close

Executive Reporting

Strategic Partnership

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free